Fongit

HekeTiss SA is a spin-off from the University Hospitals of Geneva and the University of Geneva, specializing in the manufacturing of medical and dental instruments. The company has developed TrophiPatch, an innovative cellular patch designed to enhance wound healing. This product closely resembles natural skin and is engineered from stem cells derived from human adipose tissue. TrophiPatch actively secretes various factors that facilitate the wound healing process, effectively restoring blood vessels in the affected area. By promoting efficient healing, HekeTiss aims to enable healthcare providers to offer effective and cost-efficient treatments for chronic ulcers while significantly reducing the time required for recovery.

Antion Biosciences is a Geneva-based biotechnology company focused on cell and gene engineering to develop off-the-shelf therapies for diseases with significant unmet medical needs. Its proprietary technology enables multiplexed, modular modification of therapeutic cells, supporting allogeneic approaches and the potential to enhance safety and efficacy of next-generation therapies. The company is repurposing its miCAR19 programs for autoimmune diseases and advancing its lead product miCAR7, backed by in vivo proof-of-concept data. By leveraging multiplex engineering, Antion aims to deliver best-in-class treatments for B-cell-driven autoimmune conditions, with notable preclinical progress and human proof-of-concept milestones to date.

HeroSupport is a medical device manufacturing company founded in 2019 and based in Veyrier, Geneva. The company specializes in creating medical immobilization devices designed to enhance patient comfort during clinical procedures. Its innovative technology transforms imaging and treatment tables into personalized support solutions, specifically catering to the needs of patients undergoing prone breast radiotherapy. This approach allows patients to benefit from tailored support, eliminating the need for them to adjust to the standard table. By improving patient comfort, HeroSupport enables healthcare providers to deliver more effective and cost-efficient cancer treatment.

Founded in Geneva in 2017, KYLYS is a Swiss company specializing in biomolecule-based products. It offers innovative, safe, and effective solutions for medical, surgical, and cosmetic needs, with a focus on hyaluronic acid pearls.

Plair SA is a Swiss company specializing in the development and manufacturing of advanced systems for preventive environmental monitoring, particularly focusing on air quality. Founded in 2014 and based in Plan-les-Ouates, Switzerland, Plair SA designs instruments that enable continuous real-time measurements of fine airborne particles. Its notable products include the Rapid-E, which analyzes single aerosol particles, and the Particle Analyzer PA-300, capable of detecting, identifying, and classifying various airborne entities such as pollen, fungal spores, soot, and pollutants. The company offers solutions for airborne allergen monitoring, air quality assessment, and bioaerosol tracking, providing crucial data on atmospheric aerosol concentrations. Plair SA originated as a spin-off from the University of Geneva, reflecting its strong foundation in research and innovation.

Endotelix is a Swiss biotechnology company and a spin-off from the University of Geneva focused on antiphospholipid syndrome. It develops diagnostic tests and treatment options, aiming to deliver fast, sensitive solutions for the condition. The company provides diagnostic tools, therapies, and supports clinical research to assist clinicians in diagnosing antiphospholipid syndrome and identifying effective treatments.

EBAMed develops a non-invasive ultrasound-based device to monitor and treat heart motion using proton beams. Founded in 2018, the company is based in Geneva, Switzerland.

Terapet specializes in advanced proton therapy for cancer treatment. Founded by physicists Christina Vallgren, Marcus Palm, and Professor Raymond Miralbell from Geneva University Hospitals, the company offers precise radiotherapy that minimizes harm to healthy cells. Incorporated in 2019, Terapet is based in Geneva, Switzerland.

GliaPharm is a Swiss biotechnology company focused on developing treatments for neurological and psychiatric disorders by targeting glial cells to support brain metabolism. It has developed the GliaX platform to identify drugs that modulate glial activity and energy metabolism. The platform combines high-throughput screening using enzymatic and primary-cell assays with metabolic characterization of compounds in vitro in primary brain cell cultures and in vivo in rodent brains. Research includes various rodent models of brain aging, Alzheimer's disease, and ALS, with selective contract research organizations handling parts of the drug-development process. Founded in 2016 and based in Geneva, GliaPharm pursues glia-mediated neuroprotection and maintenance of cognitive function.

HekeTiss SA is a spin-off from the University Hospitals of Geneva and the University of Geneva, specializing in the manufacturing of medical and dental instruments. The company has developed TrophiPatch, an innovative cellular patch designed to enhance wound healing. This product closely resembles natural skin and is engineered from stem cells derived from human adipose tissue. TrophiPatch actively secretes various factors that facilitate the wound healing process, effectively restoring blood vessels in the affected area. By promoting efficient healing, HekeTiss aims to enable healthcare providers to offer effective and cost-efficient treatments for chronic ulcers while significantly reducing the time required for recovery.

ABCDx is a Geneva-based company that develops and validates biomarker panels and related diagnostics for brain injury care. It aims to identify patients at risk of severe long-term complications after traumatic brain injury or stroke and to educate clinicians on using these tests. The company is building a platform that analyzes brain biomarkers from a finger-prick blood sample to enable rapid, point-of-care diagnosis of brain injuries, supporting timely treatment decisions. Founded in 2014 by researchers from the University of Geneva and related institutes, ABCDx translates biomarker discovery and clinical validation into practical tools for stroke and brain injury management.

HeroSupport is a medical device manufacturing company founded in 2019 and based in Veyrier, Geneva. The company specializes in creating medical immobilization devices designed to enhance patient comfort during clinical procedures. Its innovative technology transforms imaging and treatment tables into personalized support solutions, specifically catering to the needs of patients undergoing prone breast radiotherapy. This approach allows patients to benefit from tailored support, eliminating the need for them to adjust to the standard table. By improving patient comfort, HeroSupport enables healthcare providers to deliver more effective and cost-efficient cancer treatment.

Quantum Integrity SA is a Swiss company based in Geneva, founded in 2017, that specializes in software development for forensic analysis of digital images. The company's technology examines images on a pixel-by-pixel basis to identify manipulations and potential forgeries, regardless of the methods or software employed in their alteration. By focusing on accuracy in forgery detection, Quantum Integrity enhances the security of cyber communications and ensures the integrity of digital media.

Founded in 2016, Quantreex offers a web-based trading platform that enables users to create automated trading strategies using artificial intelligence and machine learning. The platform designs strategies, verifies them through back tests on multiple instruments and markets, and allows clients to deploy these strategies live.

Prodibi is a professional image platform based in Geneva, Switzerland, that addresses various challenges associated with online image display, enhancing brand ROI and user engagement. Established in 2011, the platform offers a subscription-based service that simplifies the process of sharing high-quality images on web and mobile. By automatically uploading, encoding, and delivering images, Prodibi allows photographers, artists, and web publishers to showcase their work without sacrificing speed or quality. The solution effectively resolves issues such as color management, pixel density, and responsiveness, which can be time-consuming and costly for graphic designers. Prodibi’s capabilities enable users to replace images seamlessly without the need for website redesigns or new photo shoots, delivering an exceptional visual experience that aligns with the prestige of their brands.

Silver Wave is a Swiss company based in Geneva, founded by expert professionals from the pharma & medical device industries. Building on 25 years of experience, the team at Silver Wave has a leading reputation in the field of aesthetics, with experience in research and development as well as manufacturing and management that extends to many global healthcare companies. Silver Wave is built on the team’s experience and passion.

Multiwave Technologies develops breakthrough magnetic resonance imaging and positron emission tomography devices, including metamaterial MRI antennas designed by its French unit. The company aims to improve MRI image quality and support clinical decision making, including portable MRI capabilities and sensor-based performance analysis. Founded in 2015 in Switzerland, it is headquartered in Geneva and conducts research and development in France, reflecting an international footprint. The business is recognized for its metamaterial MRI antenna design and positions itself as a deep science imaging innovator in neurology and other medical imaging applications.